|1.||Ahmed, Maryam: 2 articles (01/2014 - 03/2006)|
|2.||Yin, Yuelan: 2 articles (03/2011 - 03/2008)|
|3.||Garside, Paul: 2 articles (10/2007 - 01/2006)|
|4.||Brewer, James M: 2 articles (10/2007 - 01/2006)|
|5.||Millington, Owain R: 2 articles (10/2007 - 01/2006)|
|6.||Phillips, R Stephen: 2 articles (10/2007 - 01/2006)|
|7.||Dietrich, Guido: 2 articles (01/2007 - 02/2003)|
|8.||Polley, Rosalind: 2 articles (02/2005 - 10/2004)|
|9.||Zubairi, Soombul: 2 articles (02/2005 - 10/2004)|
|10.||Kaye, Paul M: 2 articles (02/2005 - 10/2004)|
|1.||Typhoid Fever (Typhoid)
01/01/2007 - "Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens."
07/01/2011 - "Live attenuated Salmonella enterica serovar Typhi Ty21a (Ty21a) is an important vaccine strain used in clinical studies for typhoid fever and as a vaccine vector for the expression of heterologous antigens. "
08/01/2015 - "Thus, our findings suggest that the attenuated vaccine strain is a promising candidate worthy of further evaluation both as a human enteric fever vaccine and as a vaccine delivery vector for heterologous antigens."
01/01/2013 - "Attenuated Salmonella enterica serovar Typhi strain Ty21a is an important vaccine for controlling typhoid fever and serves as an oral vector for delivering heterologous antigens. "
01/01/2013 - "The numbers of typhoid-specific plasmablasts (total of ASC to Vi, O-9,12 and H-d antigens) proved equal in the vaccination groups. "
06/01/2008 - "Human and animal studies suggest that infection with these intestinal nematodes is associated with impaired cellular immunity, characterized by reduced lymphocyte proliferation in response to both parasite and heterologous antigens. "
01/01/2007 - "Although the presented results are preliminary and additional study of more sera of people infected with Salmonella Typhi is needed, it can be concluded after Chart et al., that an immunoblotting procedure incorporating O=9,12 LPS and flagellar H=d antigens is a useful method for providing serological evidence of infection with Salmonella Typhi. "
01/25/2015 - "However, FBS has a poorly characterized composition and poses risk factors, as it may be a source of xenogenic antigens and zoonotic infections. "
04/01/2010 - "Cross-reactivity with Echinococcus granulosus infection occurs in homologous and heterologous antigens and could be avoided by using different purified methods. "
02/01/2009 - "Because of this homology, heterologous antigens have been used in the immunodiagnosis and vaccine development against Leishmania infections. "
09/01/2005 - "In the case of cervical cancer, human papillomavirus (HPV) xenoantigens are readily recognised by the immune system, and their targeting has shown great promise in preclinical models of therapeutic vaccination and in clinical studies of preventative vaccination. "
04/01/2010 - "Immunization with xenogeneic antigens is an attractive approach to induce cross-reactive humoral and cellular immunity to inhibit tumor growth or angiogenesis. "
05/01/2009 - "Sequential intratumoral injection of the xenoantigens was performed in immunized mice bearing S180 tumor. "
05/01/2009 - "To investigate the therapeutic effect of sequential intratumoral injection of xenogeneic antigens in immunized tumor-bearing mice. "
01/01/2006 - "Furthermore, dendritic cells were able to prime tumor immunity when pulsed with the placental xenoantigens. "
|4.||Communicable Diseases (Infectious Diseases)
03/01/2011 - "monocytogenes is therefore a promising candidate as a safe and effective vector for the delivery of heterologous antigens to prevent zoonosis and infectious disease in poultry."
09/01/2004 - "It is suggested that the most promising area of application therefore appears to be infectious disease in which heterologous antigens are targeted and concerns for long-term antibody exposure are minimal. "
08/01/1994 - "Salmonella strains have great potential as live carriers of heterologous antigens to induce immunity against a variety of infectious diseases. "
10/01/1994 - "In addition to the previously described ability of vaccinia to induce immune responses in experimental animals, the virus has been shown to encode modulators of immune function that may, in the future, permit the use of virus to induce qualitatively different immune responses to particular heterologous antigens."
09/01/2003 - "Originating from highly efficacious vaccines securing world-wide eradication of smallpox, the most appealing use of vaccinia vectors is to serve as vaccine delivery system for heterologous antigens. "
|3.||Antigen-Antibody Complex (Immune Complex)
|6.||Immunoglobulin G (IgG)
|7.||Complement System Proteins (Complement)
|8.||Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)
|10.||Immunoglobulin M (IgM)
|2.||Transplantation (Transplant Recipients)
|4.||Homologous Transplantation (Allograft)